KOWLOON DEV (00034) announced its interim results, with shareholders' profit amounting to HK$131 million, an increase of 4.8% year-on-year.

20:10 21/08/2026

Kowloon Development (00034) announced its mid-term results for 2026, with operating revenue of approximately HK$1.186 billion, a year-on-year decrease of 51.15%; profit attributable to shareholders was HK$131 million, an increase of 4.8% year-on-year; mid-term earnings per share stood at HK$0.10, with a mid-term dividend of HK$0.10 per share.

KOWLOON DEV (00034) announced its mid-term results for 2026, with operating revenue of approximately HKD 1.186 billion, a year-on-year decrease of 51.15%; profit attributable to shareholders was HKD 131 million, an increase of 4.8% year-on-year; mid-term earnings per share were HKD 0.10, and the mid-term dividend per share was HKD 0.10.

Pharmaron Beijing (03759) shareholder Longtai Zhongxin has reduced its holdings by a total of 1.329 million shares of the company.

QUNABOX GROUP (00917) announced its interim results, with a profit attributable to shareholders of 166 million yuan, an increase of 34.89% year-on-year.

ZHONGTAIFUTURES (01461) announced its mid-term results, with a net profit attributable to the parent company of approximately 97.22 million yuan, a year-on-year increase of 198.36%.

Pharmaron Beijing (03759) shareholder Longtai Zhongxin has reduced its holdings by a total of 1.329 million shares of the company.

QUNABOX GROUP (00917) announced its interim results, with a profit attributable to shareholders of 166 million yuan, an increase of 34.89% year-on-year.

ZHONGTAIFUTURES (01461) announced its mid-term results, with a net profit attributable to the parent company of approximately 97.22 million yuan, a year-on-year increase of 198.36%.